Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and ViiV will push forward with their long-acting antivirals after touting positive early-stage results.

Claim your 7-day free trial now. ViiV Healthcare announced Wednesday the latest findings from its EMBRACE phase 2b study. The study found that N6LS (VH3810109 or VH109), given every four months in ...

Specialist HIV company ViiV Healthcare, which is majority owned by UK pharma major GSK (LSE: GSK), today announced positive findings from the company’s EMBRACE Phase IIb study. The study found that ...

White House deputy chief of staff Dan Scavino released the Oval Office’s updated look on Monday afternoon, showing five ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its plans to create a six-month regimen are shaping up. ViiV, which is ...

A working group of the House Finance Committee is recommending the elimination of the independent Office of Child Advocate to save $2 million as budget writers craft a two-year spending plan in ...

ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 and VH499. ViiV, a specialist HIV company majority owned by GSK (LSE: GSK) ...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s ...

ViiV Healthcare, majority owned by GSK (GSK), with Pfizer (PFE) (PE) and Shionogi as shareholders, announced findings from the company’s EMBRACE phase IIb study. The study found that N6LS ...

Trademarks are owned by or licensed to the ViiV Healthcare group of companies. About ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) ...

The Trump administration displayed a new view of President Donald Trump’s Oval Office, bearing 20 different ... to allow for negotiations White House threatens to veto Congress's efforts to ...